APOLLO Study, Phase 3 Clinical Trial Interest Form
UPA is supporting Disc Medicine and clinical study sites to support patient referrals for the APOLLO Study, a Phase 3 clinical trial evaluating Bitopertin, an investigational oral medication for individuals with Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP).

This form helps us manage participant interest. Filling it out does not obligate you to participate. If you live in the U.S. or Canada, please complete the information below, and UPA will contact you with more details and next steps.

Your responses will remain confidential and will not be shared without your consent.
Sign in to Google to save your progress. Learn more
First Name *
Last Name *
Email Address
*
Phone Number
*
Address
City *
State/Province *
Zip/Postal Code
Country *
Diagnosis *
What is your age? *
Have you been to a porphyria center before? If yes, which one?
Yes, I agree to be contacted by the United Porphyrias Association regarding the above listed study. Your information will never be shared without your consent per United Porphyrias Association Privacy Policy. We look forward to serving you!
Clear selection

Yes, I would like to join the United Porphyrias Association to receive news, information and updates. UPA may also contact you for research opportunities related to porphyria and rare disease.

Clear selection
Submit
Clear form
Never submit passwords through Google Forms.
This content is neither created nor endorsed by Google. - Terms of Service - Privacy Policy

Does this form look suspicious? Report